BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 13814944)

  • 1. [Immunological and hemocoagulative characteristics of serums of rabbits immunized with prothrombin, fibrinolysin (plasmin), fibrinogen and thrombin. (Experimental immuno-coagulopathy)].
    DE NICOLA P; ZANGAGLIA O; SOARDI F
    Riv Emoter Immunoematol; 1959; 6():161-78. PubMed ID: 13814944
    [No Abstract]   [Full Text] [Related]  

  • 2. BLOOD COAGULATION: PRACTICAL SIGNIFICANCE OF RECENT ADVANCES IN KNOWLEDGE OF PROTHROMBIN.
    SEEGERS WH
    Tex State J Med; 1963 Nov; 59():1068-75. PubMed ID: 14084901
    [No Abstract]   [Full Text] [Related]  

  • 3. [NEUTRALIZATION OF ANTIPLASMIN IN THE BLOOD DURING PROTECTIVE REACTIONS OF THE PHYSIOLOGIC ANTICOAGULATION SYSTEM].
    KUDRIASHOV BA; ANDREENKO GV; KALISHEVSKAIA TM
    Probl Gematol Pereliv Krovi; 1964 Apr; 9():12-5. PubMed ID: 14195816
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS].
    MATTIOLI G; RABITTI G; NAVA C
    Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on blood coagulation. I. Factors involved in the conversion of prothrombin into thrombin and of fibrinogen into fibrin].
    LONG LA; COLPRON G
    Union Med Can; 1961 Jan; 90():22-9. PubMed ID: 13763333
    [No Abstract]   [Full Text] [Related]  

  • 6. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clotting of the blood of an amphibian, Bufo marinus Linn. 1. Prothrombin-thrombin and "fibrinogen-fibrin" stages.
    HACKETT E; LEPAGE R
    Aust J Exp Biol Med Sci; 1961 Feb; 39():57-65. PubMed ID: 13710284
    [No Abstract]   [Full Text] [Related]  

  • 8. EFFECT OF PLASMIN ON FIBRINOGEN AND FIBRIN.
    GAJEWSKI J; ALEXANDER B
    Am J Physiol; 1964 Jan; 206():79-82. PubMed ID: 14111457
    [No Abstract]   [Full Text] [Related]  

  • 9. The coagulation defect in hemophilia with particular reference to the conversion of prothrombin to thrombin and the evolution of the prothrombin conversion accelerator.
    ALEXANDER B; DE VRIES A
    Blood; 1949 Jun; 4(6):752-8. PubMed ID: 18129761
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE PHYSIOPATHOLOGY OF FIBRINOLYSIS AND ITS CLINICAL AND THERAPEUTIC APPLICATIONS].
    SAMAMA M
    Transfusion (Paris); 1964; 7():99-125. PubMed ID: 14168287
    [No Abstract]   [Full Text] [Related]  

  • 11. Split products of fibrinogen after prolonged interaction with plasmin.
    Niléhn JE
    Thromb Diath Haemorrh; 1967 Aug; 18(1-2):89-100. PubMed ID: 4229209
    [No Abstract]   [Full Text] [Related]  

  • 12. [ON THE ACTIVATION OF PLASMIN IN COAGULATING BLOOD].
    KOTSCHY M
    Postepy Hig Med Dosw; 1964; 18():45-91. PubMed ID: 14200073
    [No Abstract]   [Full Text] [Related]  

  • 13. [PRELIMINARY STUDIES OF THE BLOOD COAGULATION SYSTEM IN UREMIA].
    JUSKOWA J
    Pol Arch Med Wewn; 1964; 34():1183-9. PubMed ID: 14235107
    [No Abstract]   [Full Text] [Related]  

  • 14. [THE ROLE OF THROMBIN GENERATION AND INACTIVATION IN HEMOSTATIC PHENOMENA].
    GARTNER H; LISIEWICZ J
    Acta Physiol Pol; 1964; 15():245-56. PubMed ID: 14227144
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.
    Dombret H; Scrobohaci ML; Daniel MT; Micléa JM; Castaigne S; Chomienne C; Fenaux P; Degos L
    Leukemia; 1995 Jan; 9(1):19-24. PubMed ID: 7531260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ON CHANGES IN INDIVIDUAL BLOOD COAGULATION FACTORS FOLLOWING CHEMICAL THYROIDECTOMY AND AFTER THE TREATMENT WITH THYROID AND THYROTROPIC HORMONES].
    LUSZTIG G; JOZSA L; PERNECZKY M; SZEDERKENYI J
    Z Gesamte Inn Med; 1965 Jan; 20():9-14. PubMed ID: 14265532
    [No Abstract]   [Full Text] [Related]  

  • 17. A METHOD FOR THE PREPARATION OF HUMAN PLASMINOGEN ON A LARGE SCALE.
    SHAMASH Y; RIMON A; MEGGED A; AVIRAM I
    Vox Sang; 1964; 9():191-201. PubMed ID: 14147437
    [No Abstract]   [Full Text] [Related]  

  • 18. COAGULATION DISTURBANCES DURING EXTRACORPOREAL CIRCULATION AND THE POSTOPERATIVE PERIOD.
    BLOMBAECK M; NOREN I; SENNING A
    Acta Chir Scand; 1964 May; 127():433-45. PubMed ID: 14169772
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant human prothrombin reduced blood loss in a porcine model of dilutional coagulopathy with uncontrolled bleeding.
    Hansson KM; Johansson KJ; Wingren C; Fries D; Nelander K; Lövgren A
    Blood Coagul Fibrinolysis; 2017 Apr; 28(3):244-253. PubMed ID: 27428015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of fibrinogen by plasmin: biological effects of the non-dialysable fibrinogen derivatives.
    Triantaphyllopoulos DC; Chandra S
    Thromb Diath Haemorrh Suppl; 1973; 56():113-26. PubMed ID: 4281938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.